Protocol Ledger

NCT03414658 · Phase II · ACTIVE NOT RECRUITING

The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer

Interventional Phase II clinical trial protocol NCT03414658 sponsored by Adrienne G. Waks in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-06-21 Enrollment: 100 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03414658
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)100 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03414658
Protocol FieldVerified Registry Value
NCT IdentifierNCT03414658
Consolidated Lead SponsorAdrienne G. Waks
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment100 participants (ACTUAL)
Registered Start Date2018-06-21
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI